Cancer-Targeting Compound 1 T13572
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Cancer-Targeting Compound 1, extracted from patent WO 2008021331 A2, is used in the research of hormone-related cancer.
CAS nr:
1007581-62-5
Purity:
98%
Molecular Weight:
299,35
SMILES:
N#CC1=CC=C(C2=CSC(N3C(OCC3(C)C)=O)=N2)C=C1
Formula:
C15H13N3O2S
Pathway:
Others
Target:
Others
